Viewing StudyNCT00516373



Ignite Creation Date: 2024-05-05 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00516373
Status: COMPLETED
Last Update Posted: 2024-02-22
First Post: 2007-08-13

Brief Title: A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 PARP
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
BRCA2 Protein
Ovarian Neoplasms
BRCA1 Protein
Keywords:
Name View
advanced ovarian cancer View
BRCA 1 protein View
BRCA 2 protein View
PolyADP ribosepolymerases View